ABSTRACT We report that Cas9/gRNA mediates efficient genetic modifications in Drosophila. Through targeting seven loci, we achieved a germline efficiency of up to 100%. Genes in both heterochromatin and euchromatin can be modified efficiently. Thus the Cas9/gRNA system is an attractive tool for rapid disruption of essentially any gene in Drosophila.
D
ROSOPHILA is considered as one of the best animal models due to its amenability to a wide repertoire of genetic tools including gene targeting by homologous recombination (Rong and Golic 2000; Gong and Golic 2003) . However, the traditional gene-targeting method can be considered labor intensive if one's goal is to simply generate knock-out mutations. Alternatively, designer nucleases (ZFN and TALEN) have been introduced into Drosophila to direct site-specific DNA double-strand breaks (DSBs) in the coding region of a target gene (Carroll 2011; Liu et al. 2012) . During nonhomologous end joining (NHEJ) repair of the DSBs, mutations at the cut site lead to disruption of the target gene. For both ZFN and TALEN, each chromosomal target site requires the construction of a pair of genes encoding the nuclease, which can be a significant investment if one's goal is to knock out multiple genes. Recently, the type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats) system from bacteria has been introduced into several heterologous systems for the purpose of generating targeted mutations Cong et al. 2013; Mali et al. 2013; Shen et al. 2013; Wei et al. 2013) . The CRISPR-associated nuclease Cas9 is guided to its target cut site by a small RNA molecule (gRNA), which shares a region of about 20-nt homology to its target DNA. Therefore, the same Cas9 protein can be directed to multiple chromosome sites depending solely on the sequence of the guide RNA. Here we targeted multiple genes with different gRNAs and achieved remarkable efficiency of targeted mutagenesis, including heterochromatic genes.
Results

Cas9 induced mutations at yellow
As a proof of principle for the functionality of the Cas9/ gRNA system in Drosophila, we chose the yellow locus to conduct our first target mutagenesis. We designed gRNAs to target two different sites in the yellow coding region (y1-gRNA and y2-gRNA; Supporting Information, Figure S1 ). The gRNA along with in vitro transcribed Cas9 mRNA were injected into y + w 1118 embryos. The results from targeting yellow were summarized in Table 1. For y1-gRNA, 80% of the injected F 0 males showed somatic yellow mosaicism suggesting that Cas9/y1-gRNA induced yellow mutations in somatic cells ( Figure S1C ). We crossed F 0 adults to y w flies to recover Cas9 induced yellow mutations in the germline. For y1-gRNA, between 30 and 67% of the F 0 yield at least one yellow offspring; 7-13% of the fertile flies inherited the Cas9-cut chromosome appearing as yellow mutants. For y2-gRNA, 36% of the F 0 were mosaic for yellow; 59-68% of them yield yellow offspring and 7-9% of the total progeny were yellow mutants. Sequencing identified small insertions and/or deletions (indels) at y1 or y2 in these individuals that bear signatures of nonhomologous end joining (NHEJ) repair ( Figure S1D ). Therefore, Cas9 can efficiently induce indel mutations at yellow in both the male and female germline.
Cas9 induced mutations at other euchromatic loci
To further demonstrate the functionality of the Cas9 system in Drosophila, we selected three additional euchromatic loci. Mutations of the ms(3)k81 locus cause male sterility (Fuyama 1986) . No mutation has been characterized for either CG3708 or CG9652. Results for this series of targeted mutagenesis are reported in Table 2 .
For ms(3)k81, we designed a gRNA that would result in Cas9 cutting at an RsaI restriction site. We reasoned that indels at this site would destroy the cut site and render a PCR fragment across this site resistant to RsaI digestion. Interestingly, all 17 F 0 males were sterile. Some of the sterility must be an artifact from the micro-injection as 12 of the 20 females were also sterile. However, another possibility is that some of the male sterility could be due to simultaneous disruption of both ms(3)k81 copies on homologous chromosomes in the germinal nuclei, which are determined to develop into germ cells. We subjected these sterile males along with several randomly selected F 0 female to PCR amplification followed by RsaI digestion ( Figure S2A ). While the PCR fragment from uninjected controls could be fully digested with RsaI, the PCR from F 0 flies showed no sign of digestion, suggesting that in most, if not all, of the PCR fragments, the RsaI site had been mutated due to Cas9 cutting. Our proposition was supported when we assayed the mutation frequency in the female germline. Of all the 88 progeny randomly selected from 8 fertile F 0 females, 87 were mutant for ms(3)k81 as assayed by RsaI digestion, DNA sequencing, and complementation with an existing ms(3)k81 mutation ( Figure S3 ).
For CG3708, we designed a gRNA to direct Cas9 cutting at a BpmI site ( Figure S2B ). About 35% of the randomly selected progeny carried an indel at the BpmI site as assayed by both BpmI digestion of PCR fragments and DNA sequencing ( Figure S4 ). For CG9652, we recovered two germline events with an indel out of 94 events sequenced ( Figure  S5 ). This frequency seemed rather low when compared to those from targeting the other loci. The underlying cause requires further investigations. In summary, we successfully targeted three different euchromatic loci using Cas9/gRNA. The germline frequency ranged from about 2% to essentially 100%.
Cas9 induced mutations at heterochromatic loci
The heterochromatic portion of the genome is generally considered inert. Yet it contains functional genes, some of Indel yielding F 0 /total fertile F 0 n/n, (%)
Detected mutants/total F 1 progeny n/n, (%) which are essential for viability or fertility. We selected three different heterochromatic loci for targeted mutagenesis: the kl-3 fertility factor on the Y chromosome, the light, and RpL15 loci on autosomes. For kl-3, all of the 29 F 0 males were sterile, yet only 4 of 37 F 0 females were sterile ( Table 2 ), suggesting that in all of the F 0 males, most if not all of the germ cells carried a nonfunctional kl-3 locus, possibly due to Cas9-induced indel mutations. To provide support for this proposition, we PCR amplified the Cas9 targeted region in kl-3 from individual F 0 males. DNA sequencing revealed multiple peaks around the Cas9 cut site, consistent with the PCR products being a mixture carrying different indels of kl-3 ( Figure S2D and Figure S7 ).
For the RpL15 locus, we observed something similar to that observed when targeting ms(3)k81, which might have been frequent alteration of both gene copies in addition to a possible off-target effects. Of the 800 embryos injected, none developed beyond the first-instar stage. This lethal phase matches that of existing RpL15 mutations (Schulze et al. 2001) , suggesting that both RpL15 copies had been disrupted in the injected individuals. Consistently, PCR products of the Cas9-targeted region amplified from dying F 0 larvae could not be digested with the NspI enzyme, although in wild-type DNA they could ( Figure S2C ). DNA sequencing of PCR products from F 0 animals revealed the presence of indels ( Figure S8 ).
For the light gene, DNA sequencing of 50 randomly selected F 1 adults identified 9 indel events representing a frequency of 18% ( Figure S6 )
Discussion
As this article was being prepared, Gratz et al. (2013) reported the successful application of Cas9 to induce germline mutations in the yellow gene of Drosophila. In addition, they were able to use the yellow phenotype to recover deletions of yellow, along with an insertion of a 50bp attP attachment for phiC31. The frequencies reported by Gratz and colleagues were generally lower than the frequencies that we were able to achieve. One likely cause for this difference is the fact that both the mRNA for Cas9 and the gRNA were in vitro transcribed in our study so that a large amount can be injected into the embryos. Remarkably, we were able to achieve germline targeting of ms(3)k81 at essentially 100% efficiency. To avoid any negative effects of too high efficiency, one may consider injecting less of gRNAs and/or injecting only gRNAs into flies that stably express a low amount of Cas9 protein. The results from targeting kl-3 and RpL15 suggest that such efficiency is achievable even for heterochromatic loci. (See File S1, Table S1, Table S2,  and Table S3 
CG17420-R TGACTCTTCGGCTTGCCATAAG
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Materials and methods
Fly stocks
w 1118 and yw flies were used in this study, and all flies were cultured at 25°C.
Cas9/gRNA design
For the construction of pSP6-2sNLS-spcas9 ( Figure S1B ), genomic DNA of Cas9 was amplified by standard PCR protocol from S. pyogenes genome, and then inserted into pMD18-T vector. An N-terminal XhoI restriction enzyme site and C-terminal NLS sequence were included in the above PCR product. The N-terminal CMV-SP6-NLS-3xFLAG fragment was cut from TALEN expressing vector (HUANG et al. 2011) by SalI and XhoI and inserted into the XhoI site described above. Target DNA binding sequence of customized gRNA was selected according to the previous studies in Zebrafish . To simplify the gRNA design and the following in vitro transcription procedure, we follow the target sequence principle:
5'GGA/G-N 17/18 -NGG-3'. For the convenience of molecular identification of indel mutations in our interested loci except for yellow, a restriction enzyme site was chosen around the cutting site of the target sequence. The sequences of gRNAs are listed in Table S2 .
In vitro synthesis and microinjection of Cas9-coding mRNA and gRNA For Cas9 mRNA in vitro transcription, pSP6-2sNLS-spcas9 plasmids were linearized by XbaI and recovered as corresponding templates. Transcription was carried out following the instructions of the Sp6 mMESSAGE mMACHINE Kit (Ambion, USA). The poly(A) signals were added to the 3' of capped mRNAs by E. coli Poly(A)
polymerase Kit (New England BioLabs, USA). For customized gRNA in vitro transcription, the DNA templates were obtained from the pMD19-T gRNA scaffold vector (kindly provided by Dr. J. XIONG, peking university) by PCR. The transcription was carried out with RiboMAX Large Scale RNA Production Systems-T7 Kit (Promega, USA). The
